Julie E Mangino

Author PubWeight™ 51.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother 2003 5.48
2 Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 2011 5.42
3 A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003 4.29
4 Administrative coding data, compared with CDC/NHSN criteria, are poor indicators of health care-associated infections. Am J Infect Control 2008 2.38
5 Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States. Clin Infect Dis 2011 2.15
6 Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia. Chest 2010 1.90
7 MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis 2014 1.78
8 Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2010 1.75
9 Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol 2010 1.73
10 Review of infectious diseases applications for iPhone/iPad and Android: from pocket to patient. Clin Infect Dis 2013 1.61
11 Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol 2010 1.29
12 Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol 2009 1.23
13 Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii. Pharmacotherapy 2007 1.21
14 Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction. Ann Pharmacother 2012 1.18
15 The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections. Clin Infect Dis 2011 1.16
16 Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report. Infect Control Hosp Epidemiol 2012 1.07
17 Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene. Clin Infect Dis 2011 1.04
18 Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem. J Infect 2008 1.01
19 Beyond the bundle--journey of a tertiary care medical intensive care unit to zero central line-associated bloodstream infections. Crit Care 2013 0.96
20 Reactivation of histoplasmosis after treatment with infliximab. Am J Med 2002 0.94
21 Characterization of "Mycobacterium paraffinicum" associated with a pseudo-outbreak. J Clin Microbiol 2008 0.92
22 Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq. Emerg Infect Dis 2008 0.86
23 Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy. Pharmacotherapy 2010 0.85
24 A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006. Infect Control Hosp Epidemiol 2012 0.85
25 An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series. Pharmacotherapy 2014 0.85
26 Fulminant Neisseria meningitidis: role for extracorporeal membrane oxygenation. Heart Surg Forum 2010 0.84
27 Implementing automated surveillance for tracking Clostridium difficile infection at multiple healthcare facilities. Infect Control Hosp Epidemiol 2012 0.81
28 Extracorporeal membrane oxygenation for pandemic (H1N1) 2009. Emerg Infect Dis 2009 0.81
29 Pseudo-outbreak of "Mycobacterium paraffinicum" infection and/or colonization in a tertiary care medical center. Infect Control Hosp Epidemiol 2009 0.80
30 Concerns about "Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study". Clin Infect Dis 2009 0.79
31 Clinical failures of linezolid and implications for the clinical microbiology laboratory. Emerg Infect Dis 2002 0.79
32 Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days. Interact Cardiovasc Thorac Surg 2010 0.79
33 Infection control and postexposure prophylaxis for the pregnant healthcare worker. Clin Obstet Gynecol 2012 0.78
34 Nitazoxanide versus metronidazole for Clostridium difficile-associated colitis. Clin Infect Dis 2007 0.76
35 Effect of fever on hospital presentation, diagnosis, and treatment in patients with H1N1/09 influenza. J Hosp Med 2012 0.75
36 Postvaccination Influenza 2009 H1N1 Respiratory Failure Requiring Extracorporeal Membrane Oxygenation. Case Rep Infect Dis 2011 0.75
37 Sustained reduction of central line-associated bloodstream infections in an intensive care unit using a top-down and bottom-up approach. Am J Infect Control 2013 0.75
38 Doripenem: a new addition to the carbapenem class of antimicrobials. Recent Pat Antiinfect Drug Discov 2009 0.75